JP2021535749A5 - - Google Patents
Info
- Publication number
- JP2021535749A5 JP2021535749A5 JP2021512906A JP2021512906A JP2021535749A5 JP 2021535749 A5 JP2021535749 A5 JP 2021535749A5 JP 2021512906 A JP2021512906 A JP 2021512906A JP 2021512906 A JP2021512906 A JP 2021512906A JP 2021535749 A5 JP2021535749 A5 JP 2021535749A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- peptides
- cancer
- amino acid
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025019485A JP2025069437A (ja) | 2018-09-04 | 2025-02-07 | ワクチン組成物を調製するためのプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1814362.8A GB201814362D0 (en) | 2018-09-04 | 2018-09-04 | Composition and process for preparing vaccine |
| GB1814362.8 | 2018-09-04 | ||
| PCT/EP2019/073481 WO2020048995A1 (en) | 2018-09-04 | 2019-09-03 | Process for preparing vaccine compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025019485A Division JP2025069437A (ja) | 2018-09-04 | 2025-02-07 | ワクチン組成物を調製するためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021535749A JP2021535749A (ja) | 2021-12-23 |
| JP2021535749A5 true JP2021535749A5 (https=) | 2022-11-28 |
Family
ID=63920945
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512906A Pending JP2021535749A (ja) | 2018-09-04 | 2019-09-03 | ワクチン組成物を調製するためのプロセス |
| JP2025019485A Pending JP2025069437A (ja) | 2018-09-04 | 2025-02-07 | ワクチン組成物を調製するためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025019485A Pending JP2025069437A (ja) | 2018-09-04 | 2025-02-07 | ワクチン組成物を調製するためのプロセス |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20200069786A1 (https=) |
| EP (1) | EP3847185A1 (https=) |
| JP (2) | JP2021535749A (https=) |
| KR (1) | KR20210086610A (https=) |
| CN (1) | CN113383009A (https=) |
| AU (1) | AU2019334261B2 (https=) |
| BR (1) | BR112021004075A2 (https=) |
| CA (1) | CA3110923A1 (https=) |
| CL (1) | CL2021000534A1 (https=) |
| CO (1) | CO2021004028A2 (https=) |
| EA (1) | EA202190669A1 (https=) |
| GB (1) | GB201814362D0 (https=) |
| IL (1) | IL281220A (https=) |
| MA (1) | MA53544A (https=) |
| MX (1) | MX2021002543A (https=) |
| SG (1) | SG11202101881UA (https=) |
| WO (1) | WO2020048995A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110651189B (zh) | 2017-03-03 | 2024-10-25 | 特雷斯生物有限公司 | 肽疫苗 |
| GB201804468D0 (en) * | 2018-03-21 | 2018-05-02 | Valo Therapeutics Oy | PeptiCRAd Cancer Therapy |
| TW202016131A (zh) * | 2018-05-16 | 2020-05-01 | 德商英麥提克生物技術股份有限公司 | 用於抗癌免疫治療的肽 |
| JP7642530B2 (ja) | 2018-09-04 | 2025-03-10 | トレオス バイオ リミテッド | ペプチドワクチン |
| TWI869426B (zh) * | 2019-07-30 | 2025-01-11 | 大學健康網絡 | Ｔ細胞受體及其使用方法 |
| GB202004974D0 (en) | 2020-04-03 | 2020-05-20 | Treos Bio Ltd | Coronavirus vaccine |
| CA3176326A1 (en) * | 2020-04-20 | 2021-10-28 | Boris SIMOVSKI | Method and system for identifying one or more candidate regions of one or more source proteins that are predicted to instigate an immunogenic response, and method for creating a vaccine |
| US20230190902A1 (en) * | 2020-05-29 | 2023-06-22 | Children's National Medical Center | Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame |
| CN111617238B (zh) * | 2020-06-02 | 2022-12-13 | 苏州药明康德新药开发有限公司 | 小鼠ct26结直肠癌治疗性肿瘤多肽疫苗制剂及其制备方法 |
| EP3945320A1 (en) * | 2020-07-29 | 2022-02-02 | Corporació Sanitària Parc Taulí | Improved epitope for detecting and/or quantifying autoantibodies against alpha-fetoprotein |
| EP4236981A1 (en) * | 2020-10-28 | 2023-09-06 | Follicum AB | Peptides for use in skin and hair pigmentation |
| AU2022256469A1 (en) * | 2021-04-14 | 2023-10-12 | Academisch Ziekenhuis Leiden | Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof |
| CN113144181B (zh) * | 2021-04-20 | 2022-07-19 | 徐州医科大学 | 一种靶向b7h3的dna疫苗、制备方法及应用 |
| CN114195861A (zh) * | 2022-01-05 | 2022-03-18 | 许昌学院 | 亲和肽 |
| CN115785211B (zh) * | 2022-06-10 | 2024-09-24 | 河北博海生物工程开发有限公司 | 肺癌特异性分子靶标04及其用途 |
| CN115785204B (zh) * | 2022-06-10 | 2024-02-13 | 河北博海生物工程开发有限公司 | 肺癌特异性分子靶标08及其用途 |
| WO2025227519A1 (zh) * | 2024-04-29 | 2025-11-06 | 北京臻知医学科技有限责任公司 | 一种肿瘤疫苗及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| FR2791895B1 (fr) | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
| AUPQ776100A0 (en) * | 2000-05-26 | 2000-06-15 | Australian National University, The | Synthetic molecules and uses therefor |
| GB0520067D0 (en) * | 2005-10-01 | 2005-11-09 | Cancer Rec Tech Ltd | Treatment of cancer |
| WO2008035350A1 (en) * | 2006-09-21 | 2008-03-27 | Vaxil Biotherapeutics Ltd. | Antigen specific multi epitope vaccines |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| WO2012051282A2 (en) * | 2010-10-14 | 2012-04-19 | The Ohio State University Research Foundation | Piwil2-like (pl2l) proteins-targeted cancer diagnosis and therapy |
| GB201315946D0 (en) * | 2013-09-06 | 2013-10-23 | Immune Targeting Systems Its Ltd | Oncology vaccine |
| EP3369431A1 (en) | 2017-03-03 | 2018-09-05 | Treos Bio Kft | Vaccine |
| CN110651189B (zh) | 2017-03-03 | 2024-10-25 | 特雷斯生物有限公司 | 肽疫苗 |
| EP3370065A1 (en) | 2017-03-03 | 2018-09-05 | Treos Bio Kft | Immunogenic peptides |
-
2018
- 2018-09-04 GB GBGB1814362.8A patent/GB201814362D0/en not_active Ceased
-
2019
- 2019-09-03 US US16/559,430 patent/US20200069786A1/en not_active Abandoned
- 2019-09-03 SG SG11202101881UA patent/SG11202101881UA/en unknown
- 2019-09-03 EA EA202190669A patent/EA202190669A1/ru unknown
- 2019-09-03 EP EP19765219.1A patent/EP3847185A1/en active Pending
- 2019-09-03 KR KR1020217009975A patent/KR20210086610A/ko active Pending
- 2019-09-03 CN CN201980071000.1A patent/CN113383009A/zh active Pending
- 2019-09-03 MA MA053544A patent/MA53544A/fr unknown
- 2019-09-03 AU AU2019334261A patent/AU2019334261B2/en active Active
- 2019-09-03 MX MX2021002543A patent/MX2021002543A/es unknown
- 2019-09-03 BR BR112021004075-7A patent/BR112021004075A2/pt unknown
- 2019-09-03 WO PCT/EP2019/073481 patent/WO2020048995A1/en not_active Ceased
- 2019-09-03 CA CA3110923A patent/CA3110923A1/en active Pending
- 2019-09-03 JP JP2021512906A patent/JP2021535749A/ja active Pending
-
2021
- 2021-02-26 US US17/249,362 patent/US20210236611A1/en not_active Abandoned
- 2021-03-03 IL IL281220A patent/IL281220A/en unknown
- 2021-03-04 CL CL2021000534A patent/CL2021000534A1/es unknown
- 2021-03-30 CO CONC2021/0004028A patent/CO2021004028A2/es unknown
-
2022
- 2022-02-08 US US17/650,360 patent/US20220160854A1/en not_active Abandoned
-
2025
- 2025-02-07 JP JP2025019485A patent/JP2025069437A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535749A5 (https=) | ||
| ES2836273T3 (es) | Método para el tratamiento del cáncer | |
| JP2016156828A5 (https=) | ||
| JP2021533777A5 (https=) | ||
| MX2022011411A (es) | Proteinas de union a antigeno que se unen especificamente a mage-a. | |
| JP2020500523A5 (https=) | ||
| JP2022050398A (ja) | 異なるタイプのがんに対する免疫療法で使用するための非標準起源のペプチドおよびペプチド組み合わせ | |
| BR112019020959A2 (pt) | peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer | |
| JP2016505635A5 (https=) | ||
| IL268278B2 (en) | New peptides and their combinations for immunotherapy against ovarian cancer and other cancers | |
| JP2017122120A5 (https=) | ||
| JP2017531427A5 (https=) | ||
| IL292864A (en) | New peptides and a combination of peptides and supports for use in immunotherapy in certain types of cancer | |
| JP2021502083A5 (https=) | ||
| JP2021500406A5 (https=) | ||
| BR112020027021A2 (pt) | Peptídeo, anticorpo, receptor de célula t, célula hospedeira recombinante, método in vitro de produção de linfócitos t ativados, composição farmacêutica, método de produção do peptídeo, uso do peptídeo e kit | |
| EP3666793A3 (en) | Combined t cell receptor gene therapy of cancer against mhc i and mhc ii-restricted epitopes of the tumor antigen ny-eso-1 | |
| RU2016137834A (ru) | КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ ОПУХОЛЕЙ, СВЕРХЭКСПРЕССИРУЮЩИХ HER2/neu | |
| AU2020264365C1 (en) | Novel peptides and combination of peptides for use in immunotherapy against various cancers | |
| Pierini et al. | Trial watch: DNA-based vaccines for oncological indications | |
| CA3108578A1 (en) | B*44 restricted peptides for use in immunotherapy against cancers and related methods | |
| CN106243213B (zh) | 一种肿瘤相关抗原XAGE-1b短肽及应用 | |
| TW201738266A (zh) | 用於aml和其他癌症免疫治療的新型肽和肽組合物 | |
| CA3068852A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers | |
| CA3097698A1 (en) | A*03 restricted peptides for use in immunotherapy against cancers and related methods |